Mitochondrial protein OPA1 is required for the expansion of effector CD8 T cells
Short-lived effector cells are characterized metabolically by a highly glycolytic state, driving energy and biomass acquisition, whereas memory-fated T cells have historically been described as meeting these requirements through mitochondrial metabolism. Here, we show that the mitochondrial protein optic atrophy 1 (OPA1) is critical for rapidly dividing CD8 T cells in vivo, the requirement for which is most pronounced in effector CD8 T cells. More specifically, OPA1 supports proper cell cycle initiation and progression and the viability and survival of CD8 T cells during clonal expansion. Use of mice deficient in the mitochondrial membrane fusion proteins Mitofusin 1 and 2 (MFN1/2) in both in vivo proliferation/differentiation assays and ex vivo metabolic analysis indicates that the requirement for OPA1 during cell division supersedes its role in mitochondrial fusion. We conclude that OPA1 is critical for the generation and accumulation of short-lived effector cells that arise during the response to infection.
Authors
- Benjamin A. S. Willett
- Craig M. Jackson (ORCID: https://orcid.org/0000-0001-9484-4420)
- Jared Klarquist (ORCID: https://orcid.org/0000-0002-4072-3962)
- Tonya M. Brunetti (ORCID: https://orcid.org/0000-0002-2228-2198)
- Travis G. Nemkov (ORCID: https://orcid.org/0000-0001-8566-7119)
- Angelo D’Alessandro (ORCID: https://orcid.org/0000-0002-2258-6490)
- Vincent Chen (ORCID: https://orcid.org/0000-0002-0157-6066)
- Ross M. Kedl (ORCID: https://orcid.org/0000-0002-9065-7895)
- Scott B. Thompson (ORCID: https://orcid.org/0000-0001-8270-1983)
- Anza Dareshouri
Institutions
- Colorado School of Public Health (US)
- University of Colorado Anschutz Medical Campus (US)
- University of Colorado Denver (US)
Publication Details
- Journal
- Cell Reports
- Published
- 2025-04-21
- DOI
- https://doi.org/10.1016/j.celrep.2025.115610
- Citations
- 3
- Primary Topic
- Mitochondrial Function and Pathology
- Type
- article
- Field-Weighted Citation Impact
- 2.42
Funders
- Division of Intramural Research, National Institute of Allergy and Infectious Diseases